期刊文献+

“土当归”化学成分及药理作用研究进展 被引量:4

Research progress on chemical constituents and pharmacological activities of Angelica gigas Nakai
下载PDF
导出
摘要 目的系统综述“土当归”(Angelica gigas Nakai,AGN)化学成分和药理作用的研究进展,为对其进一步深入研究和广泛使用奠定基础。方法查阅1959-2021年以来国内外相关文献63篇,进行分析和归纳总结。结果“土当归”作为我国朝鲜族常用草药,民间主要用于解毒和肿瘤治疗,现代研究表明其含有香豆素类、黄酮类、酚酸类、挥发油等化学成分,具有抗肿瘤、神经保护、免疫调节、抗菌、心脑血管保护等多重药理学活性。结论“土当归”具有较高的药用价值和广阔的开发前景,有待进一步深入研究。 Objective To summarize the chemical constituents and pharmacological effects of Angelica gigas Nakai(AGN)systematically,to lay a foundation for its in-depth research and extensive application.Methods A total of 63 relevant literatures at home and abroad from 1959 to 2021 were reviewed,analyzed and summarized.Results As a herbal medicine commonly used by the Chinese-Korean people,AGN is mainly used for detoxification and tumor treatment.Modern research shows that it contains coumarins,flavonoids,phenolic acids,volatile oils and other chemical constituents,and has multiple pharmacological activities such as anti-tumor,neuroprotection,immunoregulation,antibacterial and cardiovascular and cerebrovascular protection.Conclusion AGN has high medicinal value and broad research prospects,which need to be further studied.
作者 刘莲萱 洪霖 张会永 郭丹丹 高慧媛 吴威 LIU Lianxuan;HONG Lin;ZHANG Huiyong;GUO Dandan;GAO Huiyuan;WU Wei(Key Laboratory of Ministry of Education for TCM Viscera-State Theory and Applications,Liaoning University of Traditional Chinese Medicine,Shenyang 110847,China;Zhuhai College of Science and Technology,Zhuhai 519041,China;Affiliated Hospital of Liaoning University of Traditional Chinese Medicine,Shenyang 110032,China;Shenyang Pharmaceutical University,Shenyang 110016,China)
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2022年第6期748-759,共12页 Journal of Shenyang Pharmaceutical University
基金 岐黄学者-国家中医药领军人才支持计划(No.国中医药人教发[2018]12号) 广东省自然科学基金项目(2021A1515011485) 沈阳市中青年科技创新人才支持计划项目(RC190281)。
关键词 朝鲜当归 香豆素类 黄酮类 抗癌 神经保护 免疫调节 抗菌 Angelica gigas Nakai coumarins flavonoids antitumor neuroprotection immunoregulation antibacterial
  • 相关文献

参考文献4

二级参考文献49

  • 1杨秀伟,白云鹏,郭彩玉,刘大有.长白山产沙参属药用植物化学成分的研究[J].中药材,1993,16(7):31-32. 被引量:4
  • 2Heinlein CA, Chang C. Androgen receptor in prostate cancer. Endocr Rev 2004; 25: 276-308.
  • 3Taplin ME, Balk SP. Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence. J Cell Biochem 2004; 91: 483-90.
  • 4Zegarra-Moro OL, Schmidt LJ, Huang H, Tindall DJ. Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Res 2002; 62: 1008-13.
  • 5Chen S, Song CS, Lavrovsky Y, Bi B, Vellanoweth R, Chatterjee B, et al. Catalytic cleavage of the androgen receptor messenger RNA and functional inhibition of androgen receptor activity by a hammerhead ribozyme. Mol endocrinol 1998; 12: 1558-66.
  • 6Kuratsukuri K, Sugimura K, Harimoto K, Kawashima H, Kishimoto T. "Decoy" of androgen-responsive element induces apoptosis in LNCaP cells. Prostate 1999; 41: 121-6.
  • 7Liao X, Tang S, Thrasher JB, Griebling TL, Li B. Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer. Mol Cancer Ther 2005; 4: 505-15.
  • 8Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, et al. The influence of finasteride on the development of prostate cancer. New Engl J Med 2003; 349: 215-24.
  • 9Balk SP, Ko YJ, Bubley GJ. Biology of prostate-specific antigen. J Clin Oncol 2003; 21: 383-91.
  • 10Young CY, Montgomery BT, Andrews PE, Qui SD, Bilhartz DL, Tindall DJ. Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. Cancer Res 1991; 51: 3748-52.

共引文献22

同被引文献144

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部